NCT06457230

Brief Summary

To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired cerebellar-medial prefrontal cortex (mPFC) pulses on methamphetamine use disorder patients and to develop a novel physiotherapeutic intervention to optimise the treatment and management.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Dec 2024Sep 2026

First Submitted

Initial submission to the registry

June 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

December 24, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

1.5 years

First QC Date

June 10, 2024

Last Update Submit

June 21, 2026

Conditions

Keywords

Repetitive transcranial magnetic stimulationCerebellumMethamphetamineCortico-Cortical Paired Associative Stimulationmedial prefrontal cortex

Outcome Measures

Primary Outcomes (2)

  • Craving

    The intensity of psychological craving in MA dependents was assessed using the Visual Analogue Scale (VAS), where individuals rated their cravings on a scale from 0 to 100, with higher scores indicating greater levels of craving.

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • cognitive flexibility

    Based on tasks and scales assessing cognitive flexibility, including: 1.Probabilistic reversal learning task (The matching of symbols and pictures was reversed without informing the subjects and their cognitive flexibility in the reversed condition was assessed); 2.Volatile reversal learning task (participants were presented with two stimuli associated with their potential feedback magnitude. They were instructed to choose one of the two stimuli to receive feedback, but only one stimulus would result in feedback. ).

    Probabilistic reversal learning task and volatile reversal learning task : baseline, post-intervention, and at a follow-up session one week later;

Secondary Outcomes (6)

  • Other craving scales

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • Electroencephalographic (EEG) Electrophysiological Results

    before the intervention (baseline) and immediately after the intervention (post-intervention).

  • response inhibition

    SST task: baseline, post-intervention, and at a follow-up session one weeks later.

  • Depression

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • Anxiety

    before the intervention (baseline), immediately after the intervention (post-intervention), and at a follow-up session one weeks later.

  • +1 more secondary outcomes

Study Arms (3)

Sham Cerebellar Stimulation + Sham mPFC Stimulation Group

SHAM COMPARATOR

This is the sham stimulation group. The coil will be placed vertically over the cerebellar and mPFC brain regions, allowing participants to perceive the coil's vibration and sound without receiving effective intervention. All other stimulation parameters are identical to those in the active intervention group.

Device: Sham Intervention over cerebellum and mPFC

Cerebellar-mPFC Dual-Coil Paired-Pulse TMS Intervention Group

EXPERIMENTAL

The stimulation protocol involved delivering a pulse to the cerebellum first, followed by a pulse to the mPFC after a 6ms inter-stimulus interval (ISI). This 6ms interval was determined based on findings from our prior mechanistic study.

Device: Paired Associative Stimulation Targeting the Cerebellar-mPFC

Cerebellar Sham + Real mPFC Stimulation Group

ACTIVE COMPARATOR

This group serves as the positive control group for single-site stimulation. Participants in this group will receive real stimulation over the medial prefrontal cortex combined with sham stimulation over the cerebellum. This design allows us to determine whether the therapeutic effects of paired cerebellum-medial prefrontal cortex stimulation are attributable to the paired stimulation protocol itself, rather than to the effect of single-target stimulation of the medial prefrontal cortex alone.

Device: Sham stimulation over the cerebellum + real stimulation over the medial prefrontal cortex

Interventions

The coil will be placed vertically over the cerebellar and mPFC brain regions, allowing participants to perceive the coil's vibration and sound without receiving effective intervention. All other stimulation parameters are identical to those in the active intervention group.

Sham Cerebellar Stimulation + Sham mPFC Stimulation Group

The protocol consisted of 180 pulse trains. Each train contained 5 pulse pairs delivered over 1 second, resulting in a stimulation frequency of 5 Hz. Within each pulse pair, the cerebellum was stimulated first, followed by the mPFC after a 6-ms inter-stimulus interval (ISI). In total, 900 pulse pairs were administered, and a complete intervention session lasted 11 minutes and 57 seconds.

Cerebellar-mPFC Dual-Coil Paired-Pulse TMS Intervention Group

Participants in this group will receive sham stimulation over the cerebellum (The coil will be placed vertically over the cerebellum) combined with real stimulation over the medial prefrontal cortex.

Cerebellar Sham + Real mPFC Stimulation Group

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Methamphetamine is the primary substance of use, and the participant meets the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for moderate or severe methamphetamine use disorder;
  • aged 18 to 60 years;
  • normal or corrected-to-normal vision and hearing, and right-handedness;
  • primary school education or above, with the ability to understand the questionnaires and behavioral task instructions.

You may not qualify if:

  • Participants will be excluded if they meet any of the following criteria:
  • presence of metal objects in the body, such as metal dentures, orthodontic braces, bone fixation plates, aneurysm clips, or other metallic implants;
  • severe physical illness or chronic disease, including heart disease, severe hypertension, stroke, epilepsy, or history of head trauma;
  • comorbid psychiatric disorders, such as bipolar disorder, schizophrenia, or severe depression;
  • previous participation in transcranial magnetic stimulation- or electroencephalography-related studies;
  • refusal to participate in the study, poor compliance, or any other contraindications to transcranial magnetic stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Min Zhao, PhD

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

Study Officials

  • Min Zhao, PhD

    Shanghai Mental Health Center

    STUDY CHAIR

Central Study Contacts

Min Zhao, PhD

CONTACT

64387250 Zhao, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 13, 2024

Study Start

December 24, 2024

Primary Completion

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after de-identification, will be made available at the discretion of the corresponding author, following a formal request and execution of a data use agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations